ESMO BC 2023

ESMO BC 2023
May 11-13, 2023
Berlin, Germany

European Society for Medical Oncology Breast Cancer 2023.

Explore more information for Gilead Oncology therapies
Results (2)

Relationship of Diarrhea and Neutropenia Events with Outcomes in Patients with Metastatic Triple-Negative Breast Cancer Treated with Sacituzumab Govitecan: Post Hoc Analysis from the Phase 3 ASCENT Study

Safety Outcomes by UGT1A1 Status in the Phase 3 TROPiCS-02 Study of Sacituzumab Govitecan in HR+/HER2– Metastatic Breast Cancer